Most glaucoma decisions are not about what your reports show today. They are about what your eyes are likely to do over the next 5–10 years.
Risk stratification in glaucoma helps decide who needs treatment, who can be safely monitored, and who may be at risk of silent progression, even when tests appear normal. Dr Bhartiya explains.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
🧩 WHAT THIS REALLY MEANS
Why glaucoma care is not one-size-fits-all
Two patients can have similar reports, and very different futures.
- One may remain stable for years
- Another may lose vision slowly without obvious warning
Risk stratification is the process of identifying this difference early. It helps answer the most important question:
👉 What is likely to happen if we do nothing?
⚠️WHAT MOST PEOPLE GET WRONG
Why reports alone don’t tell the full story
Many glaucoma decisions are based only on:
These are important, but incomplete.
Because:
- Structural damage can begin before symptoms
- Functional loss appears late
- Test results can fluctuate
- “Normal” does not always mean “safe”
👉 This is where many patients are either over-treated unnecessarily, or under-treated until it’s too late
🧠 HOW RISK IS ACTUALLY ASSESSED
What we look at beyond individual test results.
Risk stratification considers patterns over time, not isolated numbers.
1. Structural changes
Subtle optic nerve or OCT changes that may precede symptoms
2. Functional trends
Visual field patterns, even when still within “normal” range
3. Rate of change
How quickly (or slowly) things are evolving
4. Individual risk factors
- Family history
- Age
- Corneal thickness
- Baseline nerve health
5. Life context
How much vision loss would affect your daily function
👉 This is not just diagnosis. It is future risk prediction.
Dr Bhartiya, along with her associates, write about the current perspectives in tackling glaucoma blindness. These include raising awareness, enhancing early detection programs, and access to care, particularly in underserved populations. Pubmed.
🔍 THREE COMMON SCENARIOS
When we treat, when we monitor, and when we watch closely
🟢 Low risk
- Stable findings
- No clear progression
👉 Safe to monitor with regular follow-up
🟡 Moderate risk
- Suspicious changes
- Uncertain progression
👉 Close monitoring or early treatment depending on context
🔴 High risk
- Clear progression
- Structural + functional change
👉 Treatment is recommended to prevent further loss
👉 The goal is not to treat everyone. The goal is to treat the right patients at the right time.
⏳ THE LONG-ARC VIEW
Why early clarity matters more than late intervention
Glaucoma does not usually cause sudden symptoms. It progresses quietly. Patients may feel:
- Slight reading difficulty
- Reduced contrast
- Night discomfort
- Slower visual processing
By the time vision feels obviously affected, damage is often already established.
👉 Risk stratification in glaucoma allows intervention before this stage.
🧍♀️WHY SECOND OPINIONS MATTER HERE
When it’s worth taking a step back
You may benefit from a second opinion if:
- You’ve been advised long-term treatment without clarity
- You’ve been told to “just monitor” without explanation
- Your reports seem normal, but symptoms persist
- Your treatment keeps changing
Sometimes, the issue is not the test. It is the interpretation.
🚨 Need clarity about your glaucoma risk?
You don’t need more reports. You need to understand what they mean over time.
👉 Request a Second Opinion Consultation
Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.
🔎 Frequently Asked Questions
What is risk stratification in glaucoma?
It is the process of assessing how likely glaucoma is to progress over time, based on multiple factors, not just current test results.
Can glaucoma be present even if tests are normal?
Yes. Early glaucoma may not show clear changes on routine tests, especially in the initial stages.
Does everyone with glaucoma need treatment?
No. Some patients can be safely monitored, while others need early intervention depending on their risk profile.
How often should glaucoma be monitored?
This depends on individual risk. Some patients need frequent follow-up, while others can be reviewed less often.
Why do different doctors give different advice?
Because glaucoma management involves judgement, not just reports. Different interpretations of risk can lead to different recommendations.
Read the research articles
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
1500+ Five Star Patient Reviews Google Business Profile
Upload your reports for a structured review.
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma
